1
|
Colombo E, Aydın EM, Canıtez İS, Polito L, Penconi M, Bossi A, Impresari E, Passarella D, Dallavalle S, Athanassopoulos CM, Pellegrino S, Şahin ID, Christodoulou MS. Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation. ACS Med Chem Lett 2023; 14:1472-1477. [PMID: 37849561 PMCID: PMC10577884 DOI: 10.1021/acsmedchemlett.3c00396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 09/26/2023] [Indexed: 10/19/2023] Open
Abstract
The conjugation of tetraphenylethylene (TPE) with podophyllotoxin, N-desacetylthiocolchicine, and cabazitaxel through a sebacic acid linker led to the formation of fluorescent nanoparticles. Dynamic light scattering (DLS) and photoluminescence spectroscopy were used for the identification and characterization of the fluorescent nanoparticles. The biological evaluation was determined in three human ovarian (KURAMOCHI, OVCAR3, OVSAHO) and three human breast (MCF7, SKBR 3, and MDA-MB231) cancer cell lines. In the case of cabazitaxel, the nanoparticles maintained the activity of the parent drug, at the low nanomolar range, while exhibiting high blue fluorescence. The internalization of the fluorescent NPs into cells was detected using immunofluorescence assay.
Collapse
Affiliation(s)
- Eleonora Colombo
- Dipartimento
di Chimica, Universitá degli Studi
di Milano, 20133 Milano, Italy
- Ann Romney
Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital and Harvard Medical
School, Boston, Massachusetts 02115, United States
| | - Elif Merve Aydın
- Koc
University Research Center for Translational Medicine (KUTTAM), Sariyer, Istanbul 34450, Turkey
| | - İdil Su Canıtez
- Koc
University Research Center for Translational Medicine (KUTTAM), Sariyer, Istanbul 34450, Turkey
| | - Laura Polito
- Istituto
di Scienze e Tecnologie Chimiche “Giulio Natta”, SCITEC−CNR, 20138 Milano, Italy
| | - Marta Penconi
- Istituto
di Scienze e Tecnologie Chimiche “Giulio Natta”, SCITEC−CNR, 20138, Milano, Italy
- SmartMatLab
Center, 20133 Milano, Italy
| | - Alberto Bossi
- Istituto
di Scienze e Tecnologie Chimiche “Giulio Natta”, SCITEC−CNR, 20138, Milano, Italy
- SmartMatLab
Center, 20133 Milano, Italy
| | - Elisa Impresari
- DISFARM,
Dipartimento di Scienze Farmaceutiche, Sezione Chimica Generale e
Organica “A. Marchesini”, Università degli Studi di Milano, 20133 Milano, Italy
| | - Daniele Passarella
- Dipartimento
di Chimica, Universitá degli Studi
di Milano, 20133 Milano, Italy
| | - Sabrina Dallavalle
- Department
of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, via Celoria 2, 20133 Milan, Italy
| | | | - Sara Pellegrino
- DISFARM,
Dipartimento di Scienze Farmaceutiche, Sezione Chimica Generale e
Organica “A. Marchesini”, Università degli Studi di Milano, 20133 Milano, Italy
| | | | - Michael S. Christodoulou
- Department
of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, via Celoria 2, 20133 Milan, Italy
| |
Collapse
|
2
|
Antoniou AI, Nordio G, Di Paolo ML, Colombo E, Gaffuri B, Polito L, Amenta A, Seneci P, Dalla Via L, Perdicchia D, Passarella D. 2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles. Pharmaceuticals (Basel) 2023; 16:ph16050722. [PMID: 37242505 DOI: 10.3390/ph16050722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/02/2023] [Accepted: 05/06/2023] [Indexed: 05/28/2023] Open
Abstract
A potent nontoxic antitumor drug, 2-hydroxyoleic acid (6, 2OHOA) used for membrane lipid therapy, was selected as a self-assembly inducer due to its ability to form nanoparticles (NPs) in water. For this purpose, it was conjugated with a series of anticancer drugs through a disulfide-containing linker to enhance cell penetration and to secure drug release inside the cell. The antiproliferative evaluation of the synthesized NP formulations against three human tumor cell lines (biphasic mesothelioma MSTO-211H, colorectal adenocarcinoma HT-29, and glioblastoma LN-229) showed that nanoassemblies 16-22a,bNPs exhibit antiproliferative activity at micromolar and submicromolar concentrations. Furthermore, the ability of the disulfide-containing linker to promote cellular effects was confirmed for most nanoformulations. Finally, 17bNP induced intracellular ROS increase in glioblastoma LN-229 cells similarly to free drug 8, and such elevated production was decreased by pretreatment with the antioxidant N-acetylcysteine. Also, nanoformulations 18bNP and 21bNP confirmed the mechanism of action of the free drugs.
Collapse
Affiliation(s)
- Antonia I Antoniou
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Giulia Nordio
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Maria Luisa Di Paolo
- Dipartimento di Medicina Molecolare, Università degli Studi di Padova, Via G. Colombo 3, 35131 Padova, Italy
| | - Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Beatrice Gaffuri
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Laura Polito
- Istituto di Scienze e Tecnologie Chimiche "Giulio Natta", SCITEC-CNR, Via G. Fantoli 16/15, 20138 Milano, Italy
| | - Arianna Amenta
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Pierfausto Seneci
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Lisa Dalla Via
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Dario Perdicchia
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| |
Collapse
|
3
|
Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles. MOLECULES (BASEL, SWITZERLAND) 2022; 28:molecules28010112. [PMID: 36615306 PMCID: PMC9822096 DOI: 10.3390/molecules28010112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2022] [Revised: 12/07/2022] [Accepted: 12/20/2022] [Indexed: 12/24/2022]
Abstract
Cannabidiol (CBD) is a biologically active compound present in the plants of the Cannabis family, used as anticonvulsant, anti-inflammatory, anti-anxiety, and more recently, anticancer drug. In this work, its use as a new self-assembly inducer in the formation of nanoparticles is validated. The target conjugates are characterized by the presence of different anticancer drugs (namely N-desacetyl thiocolchicine, podophyllotoxin, and paclitaxel) connected to CBD through a linker able to improve drug release. These nanoparticles are formed via solvent displacement method, resulting in monodisperse and stable structures having hydrodynamic diameters ranging from 160 to 400 nm. Their biological activity is evaluated on three human tumor cell lines (MSTO-211H, HT-29, and HepG2), obtaining GI50 values in the low micromolar range. Further biological assays were carried out on MSTO-211H cells for the most effective NP 8B, confirming the involvement of paclitaxel in cytotoxicity and cell death mechanism.
Collapse
|
4
|
Colombo E, Coppini DA, Maculan S, Seneci P, Santini B, Testa F, Salvioni L, Vanacore GM, Colombo M, Passarella D. Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles. RSC Adv 2022; 12:35484-35493. [PMID: 36544466 PMCID: PMC9744106 DOI: 10.1039/d2ra06306a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 12/06/2022] [Indexed: 12/14/2022] Open
Abstract
Hetero-nanoparticles self-assembled from a conjugate bearing folic acid as the targeting agent, and another bearing paclitaxel as the active agent are reported. Hetero-nanoparticles containing varying percentages of folic acid conjugates are characterised, and their biological activity is determined.
Collapse
Affiliation(s)
- Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Davide Andrea Coppini
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Simone Maculan
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Pierfausto Seneci
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Benedetta Santini
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| | - Filippo Testa
- Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano BicoccaPiazza della Scienza 220126 MilanoItaly
| | - Lucia Salvioni
- Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano BicoccaPiazza della Scienza 220126 MilanoItaly
| | - Giovanni Maria Vanacore
- Dipartimento di Scienza dei Materiali, Università degli Studi di Milano BicoccaVia Roberto Cozzi 5520125 MilanoItaly
| | - Miriam Colombo
- Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano BicoccaPiazza della Scienza 220126 MilanoItaly
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di MilanoVia Golgi 1920133 MilanoItaly
| |
Collapse
|
5
|
García C, Bernardes CES, Piedade MF, Fumagalli G, Colombo E, Díaz-Lanza AM, Reis CP, Correia I, Ascensão L, Passarella D, da Piedade MEM, Rijo P. Dehydroroyleanone as a Building Block for a Drug Delivery Platform Based on Self-Assembled Nanoparticles: Structural Studies and Chemical Modification. ACS OMEGA 2022; 7:44180-44186. [PMID: 36506152 PMCID: PMC9730763 DOI: 10.1021/acsomega.2c05353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Accepted: 11/09/2022] [Indexed: 06/17/2023]
Abstract
6,7-Dehydroroyleanone (DHR) is a caspase-induced cytotoxic abietane diterpene, frequently found on Plectranthus spp. A pharmaceutical formulation consisting of a DHR-squalene conjugate was synthesized and analyzed by different techniques such as scanning electron microscopy (SEM). The facile production of the dispersion of DHR-squalene conjugate nanoparticles in phosphate buffer (pH 7.4) suggests that this nanodelivery platform may be an effective system to improve the solubility and bioavailability of DHR, so that therapeutical systemic levels may be achieved.
Collapse
Affiliation(s)
- Catarina García
- CBIOS—Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, 1749-024Lisboa, Portugal
- Departamento
de Ciencias Biomédicas (Área de Farmacología;
Nuevos A̅gentes Antitumorales, Acción Tóxica Sobre
Células Leucémicas, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Madrid-Barcelona km. 33,600, 28805Alcalá de Henares, Madrid, España
| | - Carlos E. S. Bernardes
- Centro
de Química Estrutural, Institute of Molecular Sciences, Departamento
de Química e Bioquímica, Faculdade
de Ciências, Universidade de Lisboa, 1749-016Lisboa, Portugal
| | - M. Fátima
M. Piedade
- Centro
de Química Estrutural, Institute of Molecular Sciences, Departamento
de Química e Bioquímica, Faculdade
de Ciências, Universidade de Lisboa, 1749-016Lisboa, Portugal
- Centro
de Química Estrutural, Institute of Molecular Sciences, Instituto
Superior Técnico, Universidade de
Lisboa, 1049-001Lisboa, Portugal
| | - Gaia Fumagalli
- Dipartimento
di Chimica, Università Degli Studi
di Milano, Via Golgi 19, 20133Milano, Italy
| | - Eleonora Colombo
- Dipartimento
di Chimica, Università Degli Studi
di Milano, Via Golgi 19, 20133Milano, Italy
| | - Ana M. Díaz-Lanza
- Departamento
de Ciencias Biomédicas (Área de Farmacología;
Nuevos A̅gentes Antitumorales, Acción Tóxica Sobre
Células Leucémicas, Facultad de Farmacia, Universidad de Alcalá de Henares, Ctra. Madrid-Barcelona km. 33,600, 28805Alcalá de Henares, Madrid, España
| | - Catarina P. Reis
- Instituto
de Investigação do Medicamento (iMed.ULisboa), Faculdade
de Farmácia, Universidade de Lisboa, 1649-003Lisboa, Portugal
- Instituto
de Biofísica e Engenharia Biomédica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016Lisboa, Portugal
| | - Isabel Correia
- Centro
de Química Estrutural, Institute of Molecular Sciences, Instituto
Superior Técnico, Universidade de
Lisboa, 1049-001Lisboa, Portugal
| | - Lia Ascensão
- Centro
de Estudos do Ambiente e do Mar (CESAM), Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016Lisbon, Portugal
| | - Daniele Passarella
- Dipartimento
di Chimica, Università Degli Studi
di Milano, Via Golgi 19, 20133Milano, Italy
| | - Manuel E. Minas da Piedade
- Centro
de Química Estrutural, Institute of Molecular Sciences, Departamento
de Química e Bioquímica, Faculdade
de Ciências, Universidade de Lisboa, 1749-016Lisboa, Portugal
| | - Patrícia Rijo
- CBIOS—Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, 1749-024Lisboa, Portugal
- Instituto
de Investigação do Medicamento (iMed.ULisboa), Faculdade
de Farmácia, Universidade de Lisboa, 1649-003Lisboa, Portugal
| |
Collapse
|
6
|
Dyker G. Silica‐Mediated Monohydrolysis of Dicarboxylic Esters. European J Org Chem 2021. [DOI: 10.1002/ejoc.202101443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Gerald Dyker
- Faculty for Chemistry and Biochemistry Ruhr-University Bochum Universitätsstraße 150 44780 Bochum Germany
| |
Collapse
|
7
|
Ntungwe E, Domínguez-Martín EM, Bangay G, Garcia C, Guerreiro I, Colombo E, Saraiva L, Díaz-Lanza AM, Rosatella A, Alves MM, Reis CP, Passarella D, Rijo P. Self-Assembly Nanoparticles of Natural Bioactive Abietane Diterpenes. Int J Mol Sci 2021; 22:ijms221910210. [PMID: 34638551 PMCID: PMC8508833 DOI: 10.3390/ijms221910210] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2021] [Revised: 09/10/2021] [Accepted: 09/16/2021] [Indexed: 11/16/2022] Open
Abstract
Different approaches have been reported to enhance penetration of small drugs through physiological barriers; among them is the self-assembly drug conjugates preparation that shows to be a promising approach to improve activity and penetration, as well as to reduce side effects. In recent years, the use of drug-conjugates, usually obtained by covalent coupling of a drug with biocompatible lipid moieties to form nanoparticles, has gained considerable attention. Natural products isolated from plants have been a successful source of potential drug leads with unique structural diversity. In the present work three molecules derived from natural products were employed as lead molecules for the synthesis of self-assembled nanoparticles. The first molecule is the cytotoxic royleanone 7α-acetoxy-6β-hydroxyroyleanone (Roy, 1) that has been isolated from hairy coleus (Plectranthus hadiensis (Forssk.) Schweinf). ex Sprenger leaves in a large amount. This royleanone, its hemisynthetic derivative 7α-acetoxy-6β-hydroxy-12-benzoyloxyroyleanone (12BzRoy, 2) and 6,7-dehydroroyleanone (DHR, 3), isolated from the essential oil of thicket coleus (P. madagascariensis (Pers.) Benth.) were employed in this study. The royleanones were conjugated with squalene (sq), oleic acid (OA), and/or 1-bromododecane (BD) self-assembly inducers. Roy-OA, DHR-sq, and 12BzRoy-sq conjugates were successfully synthesized and characterized. The cytotoxic effect of DHR-sq was previously assessed on three human cell lines: NCI-H460 (IC50 74.0 ± 2.2 µM), NCI-H460/R (IC50 147.3 ± 3.7 µM), and MRC-5 (IC50 127.3 ± 7.3 µM), and in this work Roy-OA NPs was assayed against Vero-E6 cells at different concentrations (0.05, 0.1, and 0.2 mg/mL). The cytotoxicity of DHR-sq NPs was lower when compared with DHR alone in these cell lines: NCI-H460 (IC50 10.3 ± 0.5 µM), NCI-H460/R (IC50 10.6 ± 0.4 µM), and MRC-5 (IC5016.9 ± 0.5 µM). The same results were observed with Roy-OA NPs against Vero-E6 cells as was found to be less cytotoxic than Roy alone in all the concentrations tested. From the obtained DLS results, 12BzRoy-sq assemblies were not in the nano range, although Roy-OA NP assemblies show a promising size (509.33 nm), Pdl (0.249), zeta potential (−46.2 mV), and spherical morphology from SEM. In addition, these NPs had a low release of Roy at physiological pH 7.4 after 24 h. These results suggest the nano assemblies can act as prodrugs for the release of cytotoxic lead molecules.
Collapse
Affiliation(s)
- Epole Ntungwe
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
- Pharmacology Area (Pharmacognosy Laboratory), New Antitumor Compounds: Toxic Action on Leukemia Cells Research Group, Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100–Campus Universitario, 28805 Alcalá de Henares, Spain;
| | - Eva María Domínguez-Martín
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
- Pharmacology Area (Pharmacognosy Laboratory), New Antitumor Compounds: Toxic Action on Leukemia Cells Research Group, Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100–Campus Universitario, 28805 Alcalá de Henares, Spain;
| | - Gabrielle Bangay
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
- Pharmacology Area (Pharmacognosy Laboratory), New Antitumor Compounds: Toxic Action on Leukemia Cells Research Group, Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100–Campus Universitario, 28805 Alcalá de Henares, Spain;
| | - Catarina Garcia
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
- Pharmacology Area (Pharmacognosy Laboratory), New Antitumor Compounds: Toxic Action on Leukemia Cells Research Group, Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100–Campus Universitario, 28805 Alcalá de Henares, Spain;
| | - Iris Guerreiro
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
| | - Eleonora Colombo
- Department of Chemistry, University of Milan, Via Golgi 19, 20133 Milano, Italy; (E.C.); (D.P.)
| | - Lucilia Saraiva
- LAQV-Faculty of Pharmacy of University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal;
| | - Ana María Díaz-Lanza
- Pharmacology Area (Pharmacognosy Laboratory), New Antitumor Compounds: Toxic Action on Leukemia Cells Research Group, Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100–Campus Universitario, 28805 Alcalá de Henares, Spain;
| | - Andreia Rosatella
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
- iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal;
| | - Marta M. Alves
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1, 1049-001 Lisboa, Portugal;
| | - Catarina Pinto Reis
- iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal;
| | - Daniele Passarella
- Department of Chemistry, University of Milan, Via Golgi 19, 20133 Milano, Italy; (E.C.); (D.P.)
| | - Patricia Rijo
- CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.N.); (E.M.D.-M.); (G.B.); (C.G.); (I.G.); (A.R.)
- iMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal;
- Correspondence:
| |
Collapse
|
8
|
Vágvölgyi M, Bélteky P, Bogdán D, Nové M, Spengler G, Latif AD, Zupkó I, Gáti T, Tóth G, Kónya Z, Hunyadi A. Squalenoylated Nanoparticle Pro-Drugs of Adjuvant Antitumor 11α-Hydroxyecdysteroid 2,3-Acetonides Act as Cytoprotective Agents Against Doxorubicin and Paclitaxel. Front Pharmacol 2020; 11:552088. [PMID: 33013388 PMCID: PMC7516204 DOI: 10.3389/fphar.2020.552088] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Accepted: 08/14/2020] [Indexed: 12/14/2022] Open
Abstract
Several ecdysteroid acetonides act as adjuvant chemo-sensitizing agents against various cancer cell lines, and they can be formulated to self-assembling nanoparticle (NP) pro-drugs through a hydrolysable conjugation with squalene. In the bloodstream such squalenoylated nanoparticles dissolve into low-density lipoprotein (LDL) that allows targeting tissues containing high levels of LDL-receptors. In this work, ajugasterone C 2,3;20,22-diacetonide (3) and 11α-hydroxypoststerone 2,3-acetonide (4) were squalenoylated to obtain two new ecdysteroid pro-drugs (6 and 7) and their nano-assemblies (6NP and 7NP). A complete NMR signal assignment of 6 and 7 was achieved. Interaction of compounds 3 and 4 with chemotherapeutics was studied by the Chou-Talalay method. Compound 3 showed strong synergism with doxorubicin on a multi-drug resistant lymphoma cell line. In contrast, its nanoassembly 6NP significantly decreased the cytotoxicity of doxorubicin on these MDR cells, strongly suggesting that at least the 2,3-acetonide group was cleaved by the acidic pH of lysosomes after endocytosis of the prodrug. Further, compound 4 acted in strong antagonism with paclitaxel on MCF-7 cells and its nanoassemby 7NP also protected MCF-7 cells from the effect of paclitaxel. Our results suggest that acid-resistant A-ring substitution would be crucial to design adjuvant antitumor squalenoylated ecdysteroid prodrugs. Additionally, our results may be considered as a serendipitous discovery of a novel way to deliver cytoprotective, adaptogen ecdysteroids to healthy tissues with upregulated LDL-R.
Collapse
Affiliation(s)
- Máté Vágvölgyi
- Institute of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary
| | - Péter Bélteky
- Department of Applied and Environmental Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary
| | - Dóra Bogdán
- Department of Organic Chemistry, Semmelweis University, Budapest, Hungary.,Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Budapest, Hungary
| | - Márta Nové
- Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary
| | - Gabriella Spengler
- Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary
| | - Ahmed D Latif
- Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary
| | - István Zupkó
- Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.,Interdisciplinary Centre for Natural Products, University of Szeged, Szeged, Hungary
| | - Tamás Gáti
- Servier Research Institute of Medicinal Chemistry (SRIMC), Budapest, Hungary
| | - Gábor Tóth
- NMR Group, Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, Budapest, Hungary
| | - Zoltán Kónya
- Department of Applied and Environmental Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.,MTA-SZTE Reaction Kinetics and Surface Chemistry Research Group, University of Szeged, Szeged, Hungary
| | - Attila Hunyadi
- Institute of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.,Interdisciplinary Centre for Natural Products, University of Szeged, Szeged, Hungary
| |
Collapse
|
9
|
Colombo E, Polito L, Biocotino M, Marzullo P, Hyeraci M, Via LD, Passarella D. New Class of Betulinic Acid-Based Nanoassemblies of Cabazitaxel, Podophyllotoxin, and Thiocolchicine. ACS Med Chem Lett 2020; 11:895-898. [PMID: 32435402 DOI: 10.1021/acsmedchemlett.9b00668] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Accepted: 02/28/2020] [Indexed: 12/12/2022] Open
Abstract
Betulinic acid is validated as a new self-assembly inducer for the formation of nanoparticles (NPs) in combination with different drugs. The target compounds are characterized by the presence of anticancer drugs acting on tubulin dynamics and of a linker that could be a carbon chain or a triazole-based one. Nanoparticles formed are characterized and their biological activity is evaluated.
Collapse
Affiliation(s)
- Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Laura Polito
- CNR-ISTM, Via G. Fantoli 16/15, 20138 Milano, Italy
| | - Michele Biocotino
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Paola Marzullo
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Mariafrancesca Hyeraci
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Lisa Dalla Via
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| |
Collapse
|
10
|
Colombo E, Biocotino M, Frapporti G, Randazzo P, Christodoulou MS, Piccoli G, Polito L, Seneci P, Passarella D. Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers. Pharmaceutics 2019; 11:E422. [PMID: 31434235 PMCID: PMC6723367 DOI: 10.3390/pharmaceutics11080422] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2019] [Revised: 08/02/2019] [Accepted: 08/08/2019] [Indexed: 12/17/2022] Open
Abstract
The disaccharide trehalose is an autophagy inducer, but its pharmacological application is severely limited by its poor pharmacokinetics properties. Thus, trehalose was coupled via suitable spacers with squalene (in 1:2 and 1:1 stoichiometry) and with betulinic acid (1:2 stoichiometry), in order to yield the corresponding nanolipid-trehalose conjugates 1-Sq-mono, 2-Sq-bis and 3-Be-mono. The conjugates were assembled to produce the corresponding nano-assemblies (NAs) Sq-NA1, Sq-NA2 and Be-NA3. The synthetic and assembly protocols are described in detail. The resulting NAs were characterized in terms of loading and structure, and tested in vitro for their capability to induce autophagy. Our results are presented and thoroughly commented upon.
Collapse
Affiliation(s)
- Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Michele Biocotino
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy
| | - Giulia Frapporti
- CIBIO, Università di Trento, Via Sommarive 9, 38123 Povo (TN), Italy
| | - Pietro Randazzo
- Promidis Srl, San Raffaele Scientific Research Park, Torre San Michele 1, Via Olgettina 60, 20132 Milan, Italy
| | - Michael S Christodoulou
- DISFARM, Sezione di Chimica Generale e Organica "A. Marchesini", Universitdegli Studi di Milano, via Venezian 21, 20133 Milano, Italy
| | - Giovanni Piccoli
- CIBIO, Università di Trento, Via Sommarive 9, 38123 Povo (TN), Italy
| | | | - Pierfausto Seneci
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy.
| |
Collapse
|
11
|
Fumagalli G, Polito L, Colombo E, Foschi F, Christodoulou MS, Galeotti F, Perdicchia D, Bassanini I, Riva S, Seneci P, García-Argáez A, Dalla Via L, Passarella D. Self-assembling Releasable Thiocolchicine-Diphenylbutenylaniline Conjugates. ACS Med Chem Lett 2019; 10:611-614. [PMID: 30996805 PMCID: PMC6466830 DOI: 10.1021/acsmedchemlett.8b00605] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2018] [Accepted: 12/31/2018] [Indexed: 02/05/2023] Open
Abstract
The design and the synthesis of new self-assembling conjugates is reported. The target compounds are characterized by the presence of a self-immolative linker that secures a controlled release induced by lipase cleavage. 4-(1,2-Diphenylbut-1-en-1-yl)aniline is used as a self-assembling inducer and amino-thiocolchicine as prototype of drug. The release of thiocolchicine derivative has been demonstrated in vitro in the presence of porcine pancreatic lipase and Celite-supported lipase. The formation of nanoparticles is confirmed by dynamic light scattering, atomic force microscopy, and fluorescence microscopy. The antiproliferative activity has been proved on two human cancer cell lines.
Collapse
Affiliation(s)
- Gaia Fumagalli
- Dipartimento di
Chimica, Università degli Studi di
Milano, Via Golgi 19, 20133 Milano, Italy
| | - Laura Polito
- CNR-ISTM, Via G. Fantoli 16/15, 20138 Milano, Italy
| | - Eleonora Colombo
- Dipartimento di
Chimica, Università degli Studi di
Milano, Via Golgi 19, 20133 Milano, Italy
| | - Francesca Foschi
- Dipartimento di
Chimica, Università degli Studi di
Milano, Via Golgi 19, 20133 Milano, Italy
| | | | | | - Dario Perdicchia
- Dipartimento di
Chimica, Università degli Studi di
Milano, Via Golgi 19, 20133 Milano, Italy
| | - Ivan Bassanini
- Istituto di Chimica
del Riconoscimento Molecolare-C.N.R.-ICRM, Via Mario Bianco 9, 20131 Milano, Italy
| | - Sergio Riva
- Istituto di Chimica
del Riconoscimento Molecolare-C.N.R.-ICRM, Via Mario Bianco 9, 20131 Milano, Italy
| | - Pierfausto Seneci
- Dipartimento di
Chimica, Università degli Studi di
Milano, Via Golgi 19, 20133 Milano, Italy
| | - Aída García-Argáez
- Dipartimento di Scienze del Farmaco, Università
degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
- Fondazione per la Biologia
e la Medicina della Rigenerazione T.E.S.-Tissue Engineering and Signalling
Onlus, Via F. Marzolo
13, 35131 Padova, Italy
| | - Lisa Dalla Via
- Dipartimento di Scienze del Farmaco, Università
degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Daniele Passarella
- Dipartimento di
Chimica, Università degli Studi di
Milano, Via Golgi 19, 20133 Milano, Italy
| |
Collapse
|
12
|
Fumagalli G, Giorgi G, Vágvölgyi M, Colombo E, Christodoulou MS, Collico V, Prosperi D, Dosio F, Hunyadi A, Montopoli M, Hyeraci M, Silvani A, Lesma G, Via LD, Passarella D. Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates To Overcome Cancer Resistance. ACS Med Chem Lett 2018; 9:468-471. [PMID: 29795761 PMCID: PMC5949839 DOI: 10.1021/acsmedchemlett.8b00078] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2018] [Accepted: 04/17/2018] [Indexed: 12/22/2022] Open
Abstract
Heteronanoparticles (H-NPs) consisting of conjugates characterized by a squalene tail linked to doxorubicin and ecdysteroid derivatives are presented. Biological evaluation on A2780ADR cell line confirms not only the maintenance of the activity of the parental drug but also the ability to overcome cancer resistance. The in vitro cell uptake was demonstrated, and the involvement of an endosomal-mediated pathway was suggested.
Collapse
Affiliation(s)
- Gaia Fumagalli
- Dipartimento di Chimica, Università degli Studi di Milano, Milano 20133, Italy
| | - Giulia Giorgi
- Dipartimento di Chimica, Università degli Studi di Milano, Milano 20133, Italy
| | - Máté Vágvölgyi
- Szegedi Tudomanyegyetem (SZTE), Institute of Pharmacognosy, University of Szeged, 6720 Szeged, Hungary
| | - Eleonora Colombo
- Dipartimento di Chimica, Università degli Studi di Milano, Milano 20133, Italy
| | - Michael S Christodoulou
- DISFARM, Sezione "A. Marchesini", Università degli Studi di Milano, Via Venezian 21, 20133 Milano, Italy
| | - Veronica Collico
- Dipartimento di Biotecnologie e Bioscienze, Università Milano Bicocca, P.zza della Scienza 2, 20126 Milano, Italy
| | - Davide Prosperi
- Dipartimento di Biotecnologie e Bioscienze, Università Milano Bicocca, P.zza della Scienza 2, 20126 Milano, Italy
| | - Franco Dosio
- Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, Torino 10125, Italy
| | - Attila Hunyadi
- Szegedi Tudomanyegyetem (SZTE), Institute of Pharmacognosy, University of Szeged, 6720 Szeged, Hungary
| | - Monica Montopoli
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Mariafrancesca Hyeraci
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Alessandra Silvani
- Dipartimento di Chimica, Università degli Studi di Milano, Milano 20133, Italy
| | - Giordano Lesma
- Dipartimento di Chimica, Università degli Studi di Milano, Milano 20133, Italy
| | - Lisa Dalla Via
- Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Via F. Marzolo 5, 35131 Padova, Italy
| | - Daniele Passarella
- Dipartimento di Chimica, Università degli Studi di Milano, Milano 20133, Italy
| |
Collapse
|
13
|
Fumagalli G, Stella B, Pastushenko I, Ricci F, Christodoulou MS, Damia G, Mazza D, Arpicco S, Giannini C, Morosi L, Dosio F, Sotiropoulou PA, Passarella D. Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates. ACS Med Chem Lett 2017; 8:953-957. [PMID: 28947943 PMCID: PMC5601370 DOI: 10.1021/acsmedchemlett.7b00262] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Accepted: 08/01/2017] [Indexed: 11/29/2022] Open
Abstract
The preparation of heteronanoparticles (NPs) with doxorubicin (DOXO) and cyclopamine (CYP) conjugates is presented. Biological evaluation on A431 cell lines confirms the maintenance of the activity of the parental drugs. The in vivo study shows that self-assembled NPs reduce tumor growth and toxicity of chemotherapy.
Collapse
Affiliation(s)
- Gaia Fumagalli
- Dipartimento
di Chimica, Università degli Studi
di Milano, Milano 20133, Italy
| | - Barbara Stella
- Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Torino 10125, Italy
| | - Ievgenia Pastushenko
- Interdisciplinary
Research Institute (IRIBHM), Université
Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Francesca Ricci
- Laboratory
of Molecular Pharmacology, IRCCS-Istituto
di Ricerche Farmacologiche Mario Negri, Milano 20156, Italy
| | | | - Giovanna Damia
- Laboratory
of Molecular Pharmacology, IRCCS-Istituto
di Ricerche Farmacologiche Mario Negri, Milano 20156, Italy
| | - Davide Mazza
- Centro
di Imaging Sperimentale San Raffaele Scientific Institute, Milano 20132, Italy
- Centro
Europeo di Nanomedicina, Milano 20133, Italy
| | - Silvia Arpicco
- Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Torino 10125, Italy
| | - Clelia Giannini
- Dipartimento
di Chimica, Università degli Studi
di Milano, Milano 20133, Italy
| | - Lavinia Morosi
- Laboratory
of Cancer Pharmacology, IRCCS-Istituto di
Ricerche Farmacologiche Mario Negri, Milano 20156, Italy
| | - Franco Dosio
- Dipartimento
di Scienza e Tecnologia del Farmaco, Università
degli Studi di Torino, Torino 10125, Italy
| | - Panagiota A. Sotiropoulou
- Interdisciplinary
Research Institute (IRIBHM), Université
Libre de Bruxelles (ULB), Brussels 1070, Belgium
| | - Daniele Passarella
- Dipartimento
di Chimica, Università degli Studi
di Milano, Milano 20133, Italy
| |
Collapse
|